CCND1, cyclin D1, 595

N. diseases: 859; N. variants: 12
Disease: Non-small cell lung cancer stage III ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0278506
Disease: Non-small cell lung cancer stage III
Non-small cell lung cancer stage III 		0.010 AlteredExpression disease BEFREE However, for 126 stage III NSCLCs, reduced expression of cyclin D2 was adversely associated with recurrence-free survival (RFS) (hazard ratio [HR]=3.71, 95% CI=1.54-13.17; P=0.01), independent of histology and expression of cyclin D1. 22534667 2012